NF D'antonio, NJ D'antonio… - US Patent 7,927,307, 2011 - Google Patents Illllllllllllllllllllllllllllllllllllllllllllllllli US007927307B2 (12) United States Patent ao) Patent no.: us 7,927,307 B2 D'Antonio et al. (45) Date of Patent: Apr. 19,2011 (54) (75) (73) (*) (21) (22) (86) (87) (65) (60) (51) (52) (58) HYPODERMIC INJECTION SYSTEM Inventors: Nicholas F. D'Antonio, ... Related articles - All 3 versions
JW Lee, SO Choi, EI Felner… - Small, 2011 - Wiley Online Library ... The clinical impact of biotechnology has been constrained by the limitations of traditional hypodermicinjection of biopharmaceuticals. Microneedle patches have been proposed as a minimally invasive alternative. In this study ... Cited by 3 - Related articles - All 3 versions
R Chen, J Xue… - Toxicology and Applied Pharmacology, 2011 - Elsevier ... its possible mechanisms. A mouse model with myocardial fibrosis was induced by hypodermicinjection of isoprenaline while the mice were simultaneously treated with 40 and 80 mg/kg osthole for 40 days. After the addition ...
J Gupta, DD Denson, EI Felner… - The Clinical Journal of …, 2011 - journals.lww.com ... Discussion: This study demonstrates for the first time that microneedle-based lidocaine injection is as rapid and as effective as hypodermicinjection in inducing local anesthesia while resulting in significantly less pain during injection. (C) 2011 Lippincott Williams & Wilkins, Inc. ... Related articles - All 4 versions
H Yamanaka, T Oue, S Uehara… - Journal of Pediatric …, 2011 - Elsevier ... 1.4. Administration of forskolin to the mouse xenograft model. For the establishment of tumor xenograft model, 10 female BALB/c-nu/nu mice were administered a single hypodermicinjection containing 10 7 cells of each RMS cell line. ... Related articles - All 3 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
